Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aerovate Therapeutics, Inc.

9.80
+0.0000
Volume:- -
Turnover:- -
Market Cap:284.05M
PE:-5.76
High:9.80
Open:9.80
Low:9.80
Close:9.80
Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 Nov 2024

M&A deals roundup: AbbVie, Blackstone, Take-Two Interactive and more

seekingalpha
·
03 Nov 2024

BRIEF-Aerovate Therapeutics - Exchange Ratio Assumes Valuation For Aerovate Of $8.0 Million And Valuation For Jade Of $175.0 Million

Reuters
·
31 Oct 2024

Aerovate Therapeutics - Exchange Ratio Assumes Valuation for Aerovate of $8.0 Million and Valuation for Jade of $175.0 Mln

THOMSON REUTERS
·
31 Oct 2024

Aerovate Therapeutics - Upon Termination of Deal Under Specified Circumstances, Co May Be Required to Pay Jade Termination Fee of $2.3 Mln

THOMSON REUTERS
·
31 Oct 2024

Aerovate climbs on all-stock merger deal with Jade

seekingalpha
·
31 Oct 2024

Aerovate to Merge With Jade Biosciences, Pursue Kidney Treatment

Dow Jones
·
31 Oct 2024

BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement

Reuters
·
31 Oct 2024

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement

THOMSON REUTERS
·
31 Oct 2024

Aerovate Therapeutics Inc - Tom Frohlich to Lead Combined Company as CEO

THOMSON REUTERS
·
31 Oct 2024

Aerovate Therapeutics Inc - to Declare $65 Million Cash Dividend to Stockholders

THOMSON REUTERS
·
31 Oct 2024

Aerovate Therapeutics Inc - Stockholders to Own 1.6% of Combined Company

THOMSON REUTERS
·
31 Oct 2024

Aerovate Therapeutics Inc - Jade Secures $300 Million in Private Investment

THOMSON REUTERS
·
31 Oct 2024

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement

GlobeNewswire
·
31 Oct 2024